Head-to-head · WeighScore
Boston Medical Group vs Carocare Wellness
The verdict
Boston Medical Group takes it — 61.9/100 to 58.1/100.
Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Boston Medical Group is an established medical group running a 12-week compounded GLP-1 weight-loss programme.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Boston Medical Group | Carocare Wellness |
|---|---|---|
| WeighScore | 61.9/100 | 58.1/100 |
| Grade | C | C |
| Scorecard rank | #279 | #378 |
| Semaglutide | $199/mo (starting strength, rising with dose, compounded) | $170/mo (compounded) |
| Tirzepatide | Not disclosed | $200/mo (compounded) |
| Coverage | 7 states | 1 state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #279 · C
Strengths
- An established medical group with a defined 12-week programme rather than an open-ended subscription
- The price range and the 12-week total are both published, once you reach the costs page
- Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight
Where it loses points
- The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
- The 12-week programme totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
- The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page
- Semaglutide and tirzepatide are not priced separately — one range covers the whole programme
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #378 · C
Strengths
- Real, named local clinic in Houston with hands-on provider support, in-person visits and Google-reviewed patient experiences
- Low entry pricing — semaglutide from $170 and tirzepatide from $200 in month 1, with 3-month bundles ($500 / $600) that cut the effective monthly cost
- Packages include ongoing provider support, supplies and delivery
- Also offers IV hydration and NAD+ if you want broader wellness services in one place
Where it loses points
- Houston/Texas only — no nationwide telehealth, so it is not an option outside the local area
- Dose-escalating pricing climbs steeply (semaglutide reaches $330 by month 5; tirzepatide $425 by month 6)
- Compounding pharmacy is not named, and there is no LegitScript or published clinical-oversight detail
- Small single-location operation with no patient portal — booking and support run through Calendly and direct contact
- Compounded semaglutide and tirzepatide only — no brand-name or oral options
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.